Vanderbilt-Ingram Cancer Center

At year-end, it is customary to review the accomplishments of the year that is ending and look with anticipation to the year ahead. By any measure, 2009 has been a year of remarkable progress for the Vanderbilt-Ingram Cancer Center.

Breast cancer researchers gathered earlier this month for the annual San Antonio Breast Cancer Symposium. In this video interview with the American Association for Cancer Research, you will hear Vanderbilt-Ingram Cancer Center’s Dr. Carlos Arteaga discuss translational insights for clinical research and practice at the meeting, as well as his exciting research in women’s cancer as part of a Stand Up To Cancer “Dream Team.”

Cancer survivors face a unique range of physical, social and emotional challenges. The REACH for Survivorship Program is helping patients and their families navigate life as a cancer survivor.

Nashville, Tenn.– Researchers at Vanderbilt-Ingram Cancer Center, led by Xiao-ou Shu, M.D., Ph.D., professor of Medicine, have found that a higher intake of soy foods was associated with a lower risk of death and breast cancer recurrence among breast cancer patients in China. The study was published in the December 9 issue of JAMA. There [...]

William Pao, M.D., Ph.D., associate professor of Medicine, Vanderbilt-Ingram Cancer Center, has been awarded a grant from Stand Up to Cancer (SU2C) to study molecules that could speed up the search for new cancer drugs and targets. He is one of 13 young cancer investigators to earn a grant from SU2C.

Survivors and family members, physicians and staff of the Gateway-Vanderbilt Cancer Treatment Center recently celebrated the fifth anniversary since the center began offering the latest in radiation therapy to patients in and around Clarksville, Tenn. The center is a joint venture between Vanderbilt University Medical Center and Gateway Medical Center and is staffed and managed [...]

The Vanderbilt-Ingram Cancer Center has created a new call center designed to streamline access for both patients and referring providers.

By Melissa Marino With the promise of personalized cancer medicine comes an unsettling question: Even if we know the genetic profile of a patient’s tumor, do we have the corresponding therapies to treat it effectively? Right now, probably not. The online “Catalogue of Somatic Mutations in Cancer” lists more than 80,000 mutations in more than [...]